XAIR:NASDAQBeyond Air, Inc. Analysis

Beyond Air, Inc. (XAIR) is trading well below its 20‑day and 50‑day simple moving averages, with the 20‑day SMA under the 50‑day SMA, confirming a bearish price structure. The 14‑day RSI sits in the low‑40s, indicating the stock is not yet oversold and still carries downside pressure. Technical momentum is marginally positive as the MACD histogram turned positive, but the MACD line remains below the signal line, suggesting limited bullish momentum. Volatility is extreme, exceeding 130% on a 30‑day basis, and beta is very low, reflecting a stock that moves independently of the market.
Fundamentally, the company reports steep revenue growth (over 100% YoY in recent quarters) and a new purchasing agreement with a top‑3 national GPO, yet it remains loss‑making with negative earnings, high debt‑to‑equity, and negative cash flow. The valuation metrics (price‑to‑book below 0.6, price‑to‑sales under 1) point to a deep discount relative to its target price consensus, but the lack of earnings and sizable debt raise solvency concerns. Recent material news highlights continued commercial rollout of LungFit PH and participation in a major investor conference, which could improve visibility but does not immediately resolve the financial weakness.